Immunotherapy Linked to Lower Relapse Risk in MOGAD
Treatment with immunotherapy is tied to a lower risk for relapse in patients with myelin oligodendrocyte glycoprotein antibody disease (MOGAD), new research shows.
Source: medscape.com
Stay updated with breaking news from Philippe Bilodeau. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Treatment with immunotherapy is tied to a lower risk for relapse in patients with myelin oligodendrocyte glycoprotein antibody disease (MOGAD), new research shows.